Why are there no approved treatments for cognitive impairment in schizophrenia?
Publication
, Journal Article
Keefe, RSE
Published in: World Psychiatry
June 2019
Duke Scholars
Published In
World Psychiatry
DOI
ISSN
1723-8617
Publication Date
June 2019
Volume
18
Issue
2
Start / End Page
167 / 168
Location
Italy
Related Subject Headings
- Psychiatry
- 4203 Health services and systems
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keefe, R. S. E. (2019). Why are there no approved treatments for cognitive impairment in schizophrenia? World Psychiatry, 18(2), 167–168. https://doi.org/10.1002/wps.20648
Keefe, Richard S. E. “Why are there no approved treatments for cognitive impairment in schizophrenia?” World Psychiatry 18, no. 2 (June 2019): 167–68. https://doi.org/10.1002/wps.20648.
Keefe RSE. Why are there no approved treatments for cognitive impairment in schizophrenia? World Psychiatry. 2019 Jun;18(2):167–8.
Keefe, Richard S. E. “Why are there no approved treatments for cognitive impairment in schizophrenia?” World Psychiatry, vol. 18, no. 2, June 2019, pp. 167–68. Pubmed, doi:10.1002/wps.20648.
Keefe RSE. Why are there no approved treatments for cognitive impairment in schizophrenia? World Psychiatry. 2019 Jun;18(2):167–168.
Published In
World Psychiatry
DOI
ISSN
1723-8617
Publication Date
June 2019
Volume
18
Issue
2
Start / End Page
167 / 168
Location
Italy
Related Subject Headings
- Psychiatry
- 4203 Health services and systems
- 3202 Clinical sciences
- 1103 Clinical Sciences